UVI 3003 is a potent and selective RXR antagonist, used as a tool to test the contribution of RXR to transactivation by a given RXR heterodimer.
We use some essential cookies to make this website work. These cookies aren't used to track you. We'd
like
to set additional cookies to understand how you use our website. This information is used to improve
our
services.